Search for a command to run...
Vertex Pharmaceuticals Incorporated
Biotechnology
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Aug 26, 2026 |  David J. TaylorR | Stock | Sell |
| $1,001 - $15,000 |
| $547.29 |
| $526.19 |
| -3.9% |
| -4.8% |
Jan 29, 2026 | David J. TaylorR | Stock | Sell | $1,001 - $15,000 | $475.68 | $496.83 | +4.4% | +5.6% |
Aug 26, 2025 |  Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $387.18 | $381.87 | -1.4% | -3.7% |
Aug 7, 2025 | David J. TaylorR | Stock | Buy | $1,001 - $15,000 | $375.63 | $396.12 | +5.5% | +3.1% |
Jun 11, 2025 |  Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $452.44 | $468.85 | +3.6% | -0.4% |
Jun 10, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $451.52 | $479.53 | +6.2% | +2.1% |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $439.37 | $452.44 | +3.0% | -0.2% |
Mar 20, 2025 |  Byron DonaldsR | Stock | Sell | $1,001 - $15,000 | $510.18 | $489.10 | -4.1% | +2.5% |
Mar 20, 2025 | Byron DonaldsR | Stock | Sell | $1,001 - $15,000 | $510.18 | $489.10 | -4.1% | +2.5% |
Mar 13, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $502.92 | $484.22 | -3.7% | -0.8% |
Feb 24, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $481.65 | $500.28 | +3.9% | +8.4% |
Dec 11, 2024 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $468.29 | $409.56 | -12.5% | -8.4% |
Oct 23, 2024 |  Julia LetlowR | Stock | Buy | $1,001 - $15,000 | $470.05 | $450.97 | -4.1% | -7.1% |
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?
Morgan Stanley Reinstates Overweight on Vertex Pharmaceuticals, Announces $665 Price Target
Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks